Search
for
Sort by
Research 511–540 of 1000+
- Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Association of Sensorineural Hearing Loss in Patients With Alopecia Areata
- Study of the efficacy of carboxytherapy in alopecia
- A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Factors influencing alopecia areata treatment decisions: A qualitative assessment
- Histopathological investigation of clinically non‐affected perilesional scalp in alopecias detected unexpected spread of disease activities
- HR Gene Variants Identified in Mexican Patients with Alopecia Areata
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Decreased CD19+CD24hiCD38hi Regulatory B Cells in Alopecia Areata
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
- Hair Follicle Melanogenesis Reflected in Hair Pigmentation as a Developmental Factor in Alopecia Areata
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data
- Twenty‐nail dystrophy and alopecia areata in an adult male with thymoma‐associated myasthenia gravis: A case report
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Risk of autoimmune thyroid diseases in individuals with alopecia areata: A nationwide case‐control study
- Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan